HIGHLIGHTS
- who: Top from the , CNRS, Université Paris-Sud, Gustave Roussy, Université ParisSaclay, Villejuif, France have published the article: Combined therapy of colon carcinomas with an oncolytic, in the Journal: (JOURNAL)
- what: This study seeks to evaluate the combination of a CRAd bearing a ∆24 deletion in E1A with valproic acid (VPA) a histone deacetylase inhibitor for the treatment of human colon carcinomas. The authors examine the potential of combining a CRAd and VPA for the treatment of colon carcinoma. The authors provide evidence that these compounds in combination inhibited CRC growth in_vitro; and that this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.